Griffith University’s flagship for biomedical research
Griffith University’s Institute for Biomedicine and Glycomics is a multidisciplinary biomedical research institute for the discovery, development and commercialisation of drugs, vaccines and diagnostics to fight diseases of global impact. Our research targets the prevention and cure of infectious diseases, cancers and neurological conditions in a unique research environment.
Through world-class, innovative research; global collaboration; state-of-the-art facilities; world leading areas of expertise including glycomics and a focus on translating biomedical discoveries to the clinic, we strive to deliver real and immediate impact on human health globally and to create a brighter future for all.
Inspiring excellence
Through innovation and expertise in biomedical and glycomics research with a focus on technology development—from discovery through to clinical trial—we are committed to delivering life-saving diagnostics, preventions and cures to those who need them the most.
Positioned for impact
The Institute for Biomedicine and Glycomics houses facilities on Griffith University’s Gold Coast and Brisbane South (Nathan) campuses. We are positioned within South-East Queensland’s network of health and knowledge precincts, allowing for optimal connectivity with a booming biomedical industry, state-of-the-art hospitals and healthcare centres and other premier research institutes and universities.
Our Gold Coast location is based in the heart of the Gold Coast Health and Knowledge precinct—a global business destination recognised for transforming lives through healthcare innovation, new knowledge and next-generation technologies.
Our history
The Institute for Biomedicine and Glycomics was formally established on 1 July 2024. Griffith University augmented its formidable strengths in biomedical research by bringing together the outstanding discovery and translational research, infrastructure, and training expertise of the former Institute for Glycomics, Griffith Institute for Drug Discovery (GRIDD) and biomedical teams from within the Menzies Health Institute Queensland (MHIQ).
Latest news
Understanding how cells talk at the core of new health hub
03 Nov 2025
Understanding how cells communicate with each other to fuel diseases such as cancer is at the...
$2.5m NIH grant for malaria vaccine research
17 Sep 2025
Griffith University has been successful in securing a prestigious National Institute of Health...
De-mystifying common misconception about the prevalence of legionella bacteria
05 Sep 2025
There is a common misconception that legionella is only found in air conditioners and water towers,...
World-first clinical trial commences to treat spinal cord injury
14 Aug 2025
A Phase 1 human clinical trial to treat chronic spinal cord injury, the first of its kind in the...
Revolutionary saliva test for liver disease receives a boost
03 Jun 2025
A ground-breaking test to diagnose liver fibrosis has received a boost after lead researcher,...
Novel therapy being tested for treating rheumatic fever
26 Feb 2025
Painful monthly penicillin injections could be a thing of the past with Griffith University...
Contact us
Institute for Biomedicine and Glycomics
Griffith University
1 Parklands Dr
Southport QLD 4215
170 Kessels Rd
Nathan QLD 4111
